These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 37980651)

  • 21. Alterations in the RTK/Ras/PI3K/AKT pathway serve as potential biomarkers for immunotherapy outcome of diffuse gliomas.
    Han S; Wang PF; Cai HQ; Wan JH; Li SW; Lin ZH; Yu CJ; Yan CX
    Aging (Albany NY); 2021 Jun; 13(11):15444-15458. PubMed ID: 34100771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNALI1 is a prognosis-related biomarker and correlates with immune infiltrates in low grade glioma.
    Lu Y; Chang P; Bian J; Zhu L
    Cancer Biomark; 2023; 38(3):393-407. PubMed ID: 37955080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and validation of a leukocyte-associated immunoglobulin-like receptor-1 prognostic signature for lower-grade gliomas.
    Fang Z; Lin L; Tu Z; Zhu X; Li J; Luo P; Huang K; Wu L
    Cancer Med; 2023 Jan; 12(1):712-732. PubMed ID: 35702880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Construction and validation of an immune infiltration-related risk model for predicting prognosis and immunotherapy response in low grade glioma.
    Li J; Guo Q; Xing R
    BMC Cancer; 2023 Aug; 23(1):727. PubMed ID: 37543576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tetraspanins predict the prognosis and characterize the tumor immune microenvironment of glioblastoma.
    Li YC; Wu Y; Chen G; Zhu LZ; Luo X; Nie QQ; Zhang L; Zuo CJ
    Sci Rep; 2023 Aug; 13(1):13317. PubMed ID: 37587203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significance of NotchScore and JAG1 in predicting prognosis and immune response of low-grade glioma.
    Shi B; Ge F; Cai L; Yang Y; Guo X; Wu R; Fan Z; Cao B; Wang N; Si Y; Lin X; Dong W; Sun H
    Front Immunol; 2023; 14():1247288. PubMed ID: 38022677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive analysis of oxidative stress-related lncRNA signatures in glioma reveals the discrepancy of prognostic and immune infiltration.
    Shi Z; Wu Y; Zhuo Q; Zuo Y; Lin J; Shi H; Zhou H; Xu Z
    Sci Rep; 2023 May; 13(1):7731. PubMed ID: 37173373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ARL3 is downregulated and acts as a prognostic biomarker in glioma.
    Wang Y; Zhao W; Liu X; Guan G; Zhuang M
    J Transl Med; 2019 Jun; 17(1):210. PubMed ID: 31234870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
    Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
    J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasminogen Activator Urokinase Receptor Implies Immunosuppressive Features and Acts as an Unfavorable Prognostic Biomarker in Glioma.
    Zeng F; Li G; Liu X; Zhang K; Huang H; Jiang T; Zhang Y
    Oncologist; 2021 Aug; 26(8):e1460-e1469. PubMed ID: 33687124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-32 targeting PTEN enhances M2 macrophage polarization in the glioma microenvironment and further promotes the progression of glioma.
    Bao L; Li X
    Mol Cell Biochem; 2019 Oct; 460(1-2):67-79. PubMed ID: 31218569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. M2 macrophage marker CHI3L2 could serve as a potential prognostic and immunological biomarker in glioma by integrated single-cell and bulk RNA-Seq analysis.
    Qian W; Wang Q; Zhang C; Zhu J; Zhang Q; Luo C
    J Gene Med; 2023 Sep; 25(9):e3523. PubMed ID: 37147894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Novel Immune-Related Prognostic Biomarker and Target Associated With Malignant Progression of Glioma.
    Zhang Y; Yang X; Zhu XL; Wang ZZ; Bai H; Zhang JJ; Hao CY; Duan HB
    Front Oncol; 2021; 11():643159. PubMed ID: 33937046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictive significance of PRR11 in prognosis and immune infiltration of glioma patients.
    Han W; Chen L
    Mol Carcinog; 2023 Jul; 62(7):975-990. PubMed ID: 37036189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Procollagen C-protease enhancer protein is a prognostic factor for glioma and promotes glioma development by regulating multiple tumor-related pathways and immune microenvironment.
    Zhao Z; Zhao J; Wang Z; Wu Y; Zhang Z; Song Z; Miao J; Liu B; Zhang S; Sun B; Zhao Z
    Int J Immunopathol Pharmacol; 2022; 36():3946320221104548. PubMed ID: 35609253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Siglec15 is a prognostic indicator and a potential tumor-related macrophage regulator that is involved in the suppressive immunomicroenvironment in gliomas.
    Wang J; Xu L; Ding Q; Li X; Wang K; Xu S; Liu B
    Front Immunol; 2023; 14():1065062. PubMed ID: 37325664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SLC10A3 Is a Prognostic Biomarker and Involved in Immune Infiltration and Programmed Cell Death in Lower Grade Glioma.
    Ma W; Mei P
    World Neurosurg; 2023 Oct; 178():e595-e640. PubMed ID: 37543196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Prognostic Microenvironment-Related Immune Signature
    Qiu H; Li Y; Cheng S; Li J; He C; Li J
    Front Oncol; 2020; 10():580263. PubMed ID: 33425732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Classification related to immunogenic cell death predicts prognosis, immune microenvironment characteristics, and response to immunotherapy in lower-grade gliomas.
    Kuang Y; Jiang B; Zhu H; Zhou Y; Huang H; Li C; Zhang W; Li X; Cao Y
    Front Immunol; 2023; 14():1102094. PubMed ID: 37153540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas.
    Zhang H; Li X; Li Y; Chen B; Zong Z; Shen L
    Front Immunol; 2020; 11():603341. PubMed ID: 33363544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.